Business Description
Atreca Inc
NAICS : 325412
SIC : 2834
ISIN : US04965G1094
Share Class Description:
BCEL: Class ADescription
Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. It has single segment business of therapeutic drug discovery and development. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 16.7 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 17.5 | |||||
| 3-Year EPS without NRI Growth Rate | 16.1 | |||||
| 3-Year FCF Growth Rate | 18.6 | |||||
| 3-Year Book Growth Rate | -33 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.9 | |||||
| 9-Day RSI | 48.12 | |||||
| 14-Day RSI | 40.39 | |||||
| 6-1 Month Momentum % | -71.85 | |||||
| 12-1 Month Momentum % | -91.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.58 | |||||
| Quick Ratio | 1.58 | |||||
| Cash Ratio | 1.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.8 | |||||
| Shareholder Yield % | 586.35 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -167.93 | |||||
| ROA % | -81.07 | |||||
| ROIC % | -116.14 | |||||
| ROC (Joel Greenblatt) % | -131.08 | |||||
| ROCE % | -72.81 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.31 | |||||
| Price-to-Tangible-Book | 0.31 | |||||
| EV-to-EBIT | 0.22 | |||||
| EV-to-Forward-EBIT | -0.44 | |||||
| EV-to-EBITDA | 0.24 | |||||
| EV-to-Forward-EBITDA | -0.44 | |||||
| EV-to-Forward-Revenue | 9.7 | |||||
| EV-to-FCF | 0.26 | |||||
| Price-to-Net-Current-Asset-Value | 0.37 | |||||
| Price-to-Net-Cash | 0.57 | |||||
| Earnings Yield (Greenblatt) % | 454.55 | |||||
| FCF Yield % | -1940.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BCEL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Atreca Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.5 | ||
| Beta | 1.68 | ||
| Volatility % | 167.18 | ||
| 14-Day RSI | 40.39 | ||
| 14-Day ATR ($) | 0.014524 | ||
| 20-Day SMA ($) | 0.07763 | ||
| 12-1 Month Momentum % | -91.6 | ||
| 52-Week Range ($) | 0.052 - 1.2642 | ||
| Shares Outstanding (Mil) | 39.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Atreca Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Atreca Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Atreca Inc Frequently Asked Questions
What is Atreca Inc(BCEL)'s stock price today?
The current price of BCEL is $0.09. The 52 week high of BCEL is $1.26 and 52 week low is $0.05.
When is next earnings date of Atreca Inc(BCEL)?
The next earnings date of Atreca Inc(BCEL) is 2024-05-10 Est..
Does Atreca Inc(BCEL) pay dividends? If so, how much?
Atreca Inc(BCEL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers